[11C]UCB-J, a SV2A PET radioligand, has been used to explore SV2A differences in clinical populations including epilepsy [10], depression [11], and Alzheimer’s disease [12, 13]. This evidence concerns the gene SV2A and early-onset autosomal dominant Alzheimer disease.